North America Ultrasound Devices Market Size

North America Ultrasound Devices Market Analysis

The North America Ultrasound Devices Market size is estimated at USD 3.57 billion in 2024, and is expected to reach USD 4.68 billion by 2029, growing at a CAGR of 5.58% during the forecast period (2024-2029).

The outbreak of the COVID-19 pandemic pushed the medical device industry into action with a race to develop both therapeutic and preventive devices. There was an increased use of ultrasound devices during COVID-19, which positively impacted the market during the pandemic. For instance, according to the PubMed study published in August 2020, the American College of Radiology discouraged the use of routine imaging procedures such as chest radiographs and encouraged the use of ultrasound. It also stated that handheld ultrasound devices fit into a single-use plastic cover and can be easily decontaminated, making them ideal for minimizing viral contamination and spread during the pandemic. Many handheld ultrasound devices now have teleguidance capabilities that allow professionals to guide a novice user through an exam remotely, minimizing exposure, conserving personal protective equipment, and reducing patient transport for imaging procedures. Therefore, owing to such factors, the use of ultrasound devices was positively impacted during the pandemic in the North American region.

The main things that are driving the market are the growing use of diagnostic imaging, the rise of chronic diseases, and the speed with which technology is improving.

The increasing prevalence of chronic diseases in North American countries such as the United States and Canada is fueling market growth. For instance, as per the report published by the American Cancer Society in January 2022, around 19,880 women are expected to be diagnosed with ovarian cancer. It was also reported that ovarian cancer ranks fifth in cancer deaths among women. In addition, it also reported a woman's risk of getting ovarian cancer during her lifetime is about 1 in 78, and her lifetime chance of dying from ovarian cancer is about 1 in 108.

The American Cancer Society also stated that cancer mainly develops in older women. Around half of the women who were diagnosed with ovarian cancer were 63 years of age or older. It is more common in white women than in African-American women. Ultrasound is the initial and most important imaging modality for the detection of ovarian cancer. Moreover, ultrasound is also considered an accurate technique for the determination and monitoring of ovarian cancer. Therefore, such instances are anticipated to propel the market's growth over the forecast period.

Furthermore, Sonography Canada, an organization dedicated to the ultrasound sector in Canada, announced its strategic plan for the year 2023-2026 in February 2022. Owing to such strategic movements in the country, the market studied is expected to witness strong growth in Canada.

But strict changes to regulations are likely to slow the market's growth over the next few years.